Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)
Clinical trial NCT06252051 · COMPLETED
Trial details
- NCT number
- NCT06252051
- Sponsor
- Universitas Padjadjaran
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2022-03-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.